NC
AMGN icon

Nicholas Company’s Amgen AMGN Stock Holding History

Nicholas Company’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.95M Buy
16,435
+20
+0.1% +$6.85K 0.11% 155
2026
Q1 		$5.78M Hold
16,415
– – 0.11% 159
2025
Q4 		$5.37M Buy
+16,415
New +$5.21M 0.09% 175
2021
Q1 		– Sell
-145,850
Closed -$33.5M – 231
2020
Q4 		$33.5M Buy
145,850
+400
+0.3% +$92.2K 0.63% 55
2020
Q3 		$37M Sell
145,450
-45
-0% -$11.1K 0.78% 46
2020
Q2 		$34.3M Hold
145,495
– – 0.79% 42
2020
Q1 		$29.5M Buy
145,495
+75
+0.1% +$16.4K 0.83% 48
2019
Q4 		$35.1M Sell
145,420
-25
-0% -$5.51K 0.74% 48
2019
Q3 		$28.1M Hold
145,445
– – 0.63% 54
2019
Q2 		$26.8M Sell
145,445
-10
-0% -$1.79K 0.6% 57
2019
Q1 		$27.6M Buy
145,455
+35
+0% +$6.68K 0.65% 51
2018
Q4 		$28.3M Hold
145,420
– – 0.74% 47
2018
Q3 		$30.1M Sell
145,420
-30
-0% -$5.91K 0.66% 52
2018
Q2 		$26.8M Buy
+145,450
New +$25.7M 0.63% 53

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Nicholas Company's AMGN Position: Q2 2026 in Review

Nicholas Company increased its Amgen (AMGN) stake by 0.12% in Q2 2026, buying an estimated $6.85K and bringing the position to 16,435 shares worth $5.95M. The position accounts for 0.11% of the portfolio, ranked #155.

Nicholas Company first reported a position in AMGN in Q2 2018 and has held it in 14 quarters since. The position peaked at $37M in Q3 2020. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Nicholas Company held 16,435 shares of Amgen worth $5.95M as of Q2 2026.
  • Nicholas Company bought 20 Amgen shares in Q2 2026, an estimated $6.85K.
  • Amgen made up 0.11% of Nicholas Company's portfolio in Q2 2026, its #155 holding.
  • Nicholas Company first reported a position in Amgen in Q2 2018 and has held it in 14 quarters since.
  • Nicholas Company's Amgen position peaked at $37M in Q3 2020.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.